Updating on day 2 of this
NURO
run as premarket highs have it making new multi-year highs. Looks like that highest-high fib line ( around 18.90) could be sticky as it was a failure point in 2018 and a heavy traffic area in 2017, which was support at that time. Let's see what happens here and whether the 17.70-17.80 area will hold as resistance or if there's enough gas left in the tank.
I took the NURO chart out to 2019, which was the last time it traded around these levels. After plotting these fibs, wouldn't you know, the 236 and 382 lined up almost EXACTLY with today's action. The 382 could be an important level to watch as this was a prior area of "high traffic" and a support/resistance pivot in 2019. With volume surging, 382 fib line could be a key level t pay attention to.
**The big spike in trading action on July 20th stemmed from FDA news. NeuroMetrix announced that it received FDA Breakthrough Device Designation for treating fibromyalgia. Specifically, its Quell device garnered the interest of the stock market today. The device is non-invasive and is a nerve stimulator covered by 18 U.S. utility patents already. This Breakthrough Device Program aims to help patients gain quicker access to technologies like Quell that could provide more effective treatments.
“We are moving forward with a regulatory filing that could position us to launch Quell for this indication in the second half of next year.”
Shai N. Gozani, M.D., Ph .D., President and CEO of NeuroMetrix
Later this week, the company releases its Q2 results. So if NURO stock is on your list right now, keep July 22nd in mind. The company will also host a conference call before the market opens on that day. Read More On NeuroMetrix.**
Quote Source: 4 Penny Stocks To Watch As Hedge Against Dogecoin Price Drop Today
NURO
run as premarket highs have it making new multi-year highs. Looks like that highest-high fib line ( around 18.90) could be sticky as it was a failure point in 2018 and a heavy traffic area in 2017, which was support at that time. Let's see what happens here and whether the 17.70-17.80 area will hold as resistance or if there's enough gas left in the tank. I took the NURO chart out to 2019, which was the last time it traded around these levels. After plotting these fibs, wouldn't you know, the 236 and 382 lined up almost EXACTLY with today's action. The 382 could be an important level to watch as this was a prior area of "high traffic" and a support/resistance pivot in 2019. With volume surging, 382 fib line could be a key level t pay attention to.
**The big spike in trading action on July 20th stemmed from FDA news. NeuroMetrix announced that it received FDA Breakthrough Device Designation for treating fibromyalgia. Specifically, its Quell device garnered the interest of the stock market today. The device is non-invasive and is a nerve stimulator covered by 18 U.S. utility patents already. This Breakthrough Device Program aims to help patients gain quicker access to technologies like Quell that could provide more effective treatments.
“We are moving forward with a regulatory filing that could position us to launch Quell for this indication in the second half of next year.”
Shai N. Gozani, M.D., Ph .D., President and CEO of NeuroMetrix
Later this week, the company releases its Q2 results. So if NURO stock is on your list right now, keep July 22nd in mind. The company will also host a conference call before the market opens on that day. Read More On NeuroMetrix.**
Quote Source: 4 Penny Stocks To Watch As Hedge Against Dogecoin Price Drop Today
